Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

British Journal of Cancer
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. british journal of cancer
  3. regular article
  4. article
Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding
Download PDF
Download PDF
  • Regular Article
  • Open access
  • Published: 13 August 1999

Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding

  • I Fadl-Elmula1,3,
  • L Gorunova1,
  • N Mandahl1,
  • P Elfving2,
  • R Lundgren3,
  • F Mitelman1 &
  • …
  • S Heim4 

British Journal of Cancer volume 81, pages 6–12 (1999)Cite this article

  • 830 Accesses

  • 54 Citations

  • Metrics details

This article has been updated

Summary

Twenty-one multifocal urinary tract transitional cell carcinomas, mostly bladder tumours, from a total of six patients were processed for cytogenetic analysis after short-term culturing of the tumour cells. Karyotypically related, often identical, cytogenetically complex clones were found in all informative tumours from each case, including the recurrent tumours. Rearrangement of chromosome 9, leading to loss of material from the short and/or the long arm, was seen in all cases, indicating that this is an early, pathogenetically important event in transitional cell carcinogenesis. The presence of related clones with great karyotypic similarity in anatomically distinct tumours from the same bladder indicates that multifocal uroepithelial tumours have a monoclonal origin and arise via intraluminal seeding of viable cancer cells shed from the original tumour. Later lesions may develop also from cells shed from the so called second primary tumours. The relatively complex karyotypes seen in all lesions from most cases argue that the seeding of tumour cells is a late event that succeeds the acquisition by them of multiple secondary genetic abnormalities.

Similar content being viewed by others

Single-cell dissection of multifocal bladder cancer reveals malignant and immune cells variation between primary and recurrent tumor lesions

Article Open access 19 December 2024

Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting

Article 15 November 2021

Transcriptional state dynamics lead to heterogeneity and adaptive tumor evolution in urothelial bladder carcinoma

Article Open access 21 December 2023

Article PDF

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  • Badalament, RA & Schervish, EW (1996). Bladder cancer, current diagnostic methods and treatment options. Postgrad Med 100: 217–230.

    Article  CAS  Google Scholar 

  • Breul, J, Block, T, Breidenbach, H & Hartung, R (1992). Implantation metastasis after a suprapubic catheter in a case of bladder cancer. Eur Urol 22: 86–88.

    Article  CAS  Google Scholar 

  • Chern, HD, Becich, MJ, Persad, RA, Romkes, M, Smith, P, Collins, C, Li, YH & Branch, RA (1996). Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of p53 and retinoblastoma proteins. J Urol 156: 1846–1849.

    Article  CAS  Google Scholar 

  • Fadl-Elmula, I, Gorunova, L, Lundgren, R, Mandahl, N, Forsby, N, Mitelman, F & Heim, S (1998). Chromosomal abnormalities in two bladder carcinomas with secondary squamous cell differentiation. Cancer Genet Cytogenet 102: 125–130.

    Article  CAS  Google Scholar 

  • Fitzpatrick, JM, West, AB & Butler, MR (1986). Superficial bladder tumors (stage pTa grade 1 and 2). The importance of recurrence pattern following initial resection. J Urol 135: 920–922.

    Article  CAS  Google Scholar 

  • Fujimoto, K, Yamada, Y, Okajima, E, Kakizoe, T, Sasaki, H, Sugimura, T & Terada, M (1992). Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res 52: 1393–1398.

    CAS  PubMed  Google Scholar 

  • Garden, RJ, Liu, BC & Redwood, SM (1992). Bacillus Calmette-Guerin (BCG) abrogates in vitro invasion and motility of human bladder tumor cell via fibronectin interactions. J Urol 148: 900–950.

    Article  CAS  Google Scholar 

  • Gibas, Z & Gibas, L (1997). Cytogenetics of bladder cancer. Cancer Genet Cytogenet 95: 108–115.

    Article  CAS  Google Scholar 

  • Grossfeld, GD, Ginsberg, DA, Stein, JP, Bochner, BH, Esrig, D, Groshen, S, Dunn, M, Nichols, PW, Taylor, CR, Skinner, DG & Cote, RJ (1997). Thrombospondin-1 expression in bladder cancer: association with TP53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 89: 219–227.

    Article  CAS  Google Scholar 

  • Habuchi, T, Takahashi, R, Yamada, H, Kakehi, Y, Sugiyama, T & Yoshida, O (1993). Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 342: 1087–1088.

    Article  CAS  Google Scholar 

  • Harris, AL & Neal, DE (1992). Bladder cancer, field versus clonal origin. N Engl J Med 326: 759–761.

    Article  CAS  Google Scholar 

  • Heim, S (1992). Is cancer cytogenetics reducible to the molecular genetics of cancer cells?. Genes Chromosomes Cancer 5: 188–196.

    Article  CAS  Google Scholar 

  • Heney, NM, Proppe, K, Prout, GR, Griffin, PP & Shipley, WU (1983). Invasive bladder cancer: tumor configuration, lymphatic invasion and survival. J Urol 130: 895–902.

    Article  CAS  Google Scholar 

  • Heney, NM, Ahmed, S & Flanagan, MJ (1983). Superficial bladder cancer. Progression and recurrence. J Urol 130: 1083–1086.

    Article  CAS  Google Scholar 

  • Herr, HW (1997). Natural history of superficial bladder cancer: 10- to 20-year follow-up of treated patients. World J Urol 15: 84–88.

    Article  CAS  Google Scholar 

  • ISCN (1995). An International System for Human Cytogenetic Nomenclature. Mitelman F (ed.). S Karger: Basel

  • Kakizoe, T, Fujita, J, Murase, T, Matsumotoko, K & Kishi, K (1980). Transitional cell carcinoma of the bladder in patients with renal pelvis and ureteral cancer. J Urol 124: 17–19.

    Article  CAS  Google Scholar 

  • Kenworthy, P, Tanguay, S & Dinney, CP (1996). The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter. J Urol 155: 501–504.

    Article  CAS  Google Scholar 

  • Kiemeney, LA, Witjes, JA, Heijbroek, RP, Koper, NP, Verbeek, AL & Debruyne, FM (1993). Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 150: 60–64.

    Article  CAS  Google Scholar 

  • Lynch, CF & Cohen, MB (1995). Urinary system. Cancer 75: 316–345.

    Article  CAS  Google Scholar 

  • Miller, C, Mohandas, T, Wolf, D, Prokocimer, M, Rotter, V & Koeffler, HP (1986). Human TP53 gene localized to short arm of chromosome 17. Nature 319: 783–784.

    Article  CAS  Google Scholar 

  • Miyao, N, Tsai, YC, Lerner, SP, Olumi, AF, Spruk, CH, Gonzalez-Zulueta, M, Nichols, PW, Skinner, DG & Jones, PA (1993). Role of chromosome 9 in human bladder cancer. Cancer Res 53: 4066–4070.

    CAS  PubMed  Google Scholar 

  • Morton, RA, Ewing, CM, Watkins, JJ & Isaac, WB (1995). The E-cadherin cell adhesion pathway in urologic malignancies. World J Urol 13: 364–372.

    Article  Google Scholar 

  • Nicol, D (1995). BCG in bladder cancer: a warning. Aust NZ J Med 25: 275–282.

    Article  CAS  Google Scholar 

  • Parker, SL, Tong, T, Bolden, S & Wingo, PA (1996). Cancer statistics. Ca Cancer J Clin 46: 5–27.

    Article  CAS  Google Scholar 

  • Prout, GR, Barton Griffin, PP & Friedell, GH (1992). Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Group. J Urol 148: 1413–1419.

    Article  Google Scholar 

  • Reznikoff, CA, Belair, CD, Yeager, TR, Savelieva, E, Blelloch, RH, Puthenveettil, JA & Cuthill, SA (1996). Molecular genetic model of human bladder cancer pathogenesis. Semin Oncol 23: 571–584.

    CAS  PubMed  Google Scholar 

  • Richie, JP, Shipley, WU & Yagoda, A (1989). Cancer of the bladder. In: Cancer Principles and Practice of Oncology, De Vita VT, Helman S and Rosenberg SA (eds), pp. 1008–1022. JB Lippincctt: Philadelphia

  • Rosin, MP, Anwar, WA & Ward, AJ (1994). Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 54: 1929–1933.

    Google Scholar 

  • Schmitz-Dräger, BJ, Jankevicius, F & Ackermann, R (1996). Molecular biology of dissemination in bladder cancer laboratory findings and clinical significance. World J Urol 14: 190–196.

    Article  Google Scholar 

  • Sidransky, D, Frost, P, Von-Eschenbach, A, Oyasu, R, Preisinger, AC & Vogelstein, B (1992). Clonal origin of bladder cancer. N Eng J Med 326: 737–740.

    Article  CAS  Google Scholar 

  • Thompson, RA, Campbell, EW, Kramer, HC, Jacobs, SC & Naslund, MJ (1993). Late invasive recurrence despite long-term survival for superficial bladder cancer. J Urol 149: 1010–1011.

    Article  Google Scholar 

  • Union International Contre le Cancer (1978). TNM Classification of Malignant Tumors. Union International Contre le Cancer: Geneva

  • Unyime, ON & Donald, LL (1994). Therapy of superficial cancer. Curr Opin Urol 4: 275–280.

    Article  Google Scholar 

  • Williamson, MP, Elder, PA, Shaw, ME, Devlin, J & Knowles, MA (1995). P16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet 4: 1569–1577.

    Article  CAS  Google Scholar 

  • Wolf, H & Hojgaard, K (1982). Urothelial dysplasia concomitant with bladder tumors as a determinant factor for future new occurrences. Lancet 2: 134–140.

    Google Scholar 

  • World Health Organization (1973). Histological Typing of Urinary Bladder Tumors. International Histological Classification of Tumors: Geneva

  • Xu, X, Stower, MJ, Reid, NI & Garner, RC (1996). Burns PA Molecular screening of multifocal transitional cell carcinomas of the bladder using TP53 mutations as biomarkers. Clin Cancer Res 2: 1795–1800.

    CAS  PubMed  Google Scholar 

  • Yao, A & Rubin, HA (1994). Critical test of the role of population density in producing transformation. Proc Natl Acad Sci USA 91: 7712–7716.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Genetics University Hospital, Lund, S-221 85, Sweden

    I Fadl-Elmula, L Gorunova, N Mandahl & F Mitelman

  2. Department of Urology, University Hospital, Lund, S-251 87, Sweden

    P Elfving

  3. Department of Urology, Helsingborg Hospital, Helsingborg, S-251 87, Sweden

    I Fadl-Elmula & R Lundgren

  4. Department of Genetics, The Norwegian Radium Hospital and Institute for Cancer Research, Oslo, N-0310, Norway

    S Heim

Authors
  1. I Fadl-Elmula
    View author publications

    Search author on:PubMed Google Scholar

  2. L Gorunova
    View author publications

    Search author on:PubMed Google Scholar

  3. N Mandahl
    View author publications

    Search author on:PubMed Google Scholar

  4. P Elfving
    View author publications

    Search author on:PubMed Google Scholar

  5. R Lundgren
    View author publications

    Search author on:PubMed Google Scholar

  6. F Mitelman
    View author publications

    Search author on:PubMed Google Scholar

  7. S Heim
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and permissions

About this article

Cite this article

Fadl-Elmula, I., Gorunova, L., Mandahl, N. et al. Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding. Br J Cancer 81, 6–12 (1999). https://doi.org/10.1038/sj.bjc.6690643

Download citation

  • Received: 13 October 1998

  • Revised: 16 February 1999

  • Accepted: 15 March 1999

  • Published: 13 August 1999

  • Issue date: 01 September 1999

  • DOI: https://doi.org/10.1038/sj.bjc.6690643

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • cytogenetics
  • multifocal uroepithelial carcinomas
  • monoclonality
  • intraluminal seeding

This article is cited by

  • Inherent variability of cancer-specific aneuploidy generates metastases

    • Mathew Bloomfield
    • Peter Duesberg

    Molecular Cytogenetics (2016)

  • Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy

    • Michael A. Moriarty
    • Matthew A. Uhlman
    • Amit Gupta

    BMC Urology (2015)

  • Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma

    • Kunyoo Shin
    • Agnes Lim
    • Philip A. Beachy

    Nature Cell Biology (2014)

  • Recurrent and multiple bladder tumors show conserved expression profiles

    • David Lindgren
    • Sigurdur Gudjonsson
    • Mattias Höglund

    BMC Cancer (2008)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open access publishing
  • About the Editors
  • Contact
  • Special Issues
  • For Advertisers
  • Subscribe

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

British Journal of Cancer (Br J Cancer)

ISSN 1532-1827 (online)

ISSN 0007-0920 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited